Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.

Canada Pension Plan Investment Board has injected $45m into Sila Nanotechnologies, six months after Daimler led a $170m series E round.

Goldman Sachs has backed lease accounting software company LeaseQuery, in what appears to be the lease accounting software provider's first round.

UCSD-founded Shape Therapeutics has collected series A cash from NEA and CureDuchenne Ventures to progress its RNA gene editing technology.

David Snow has moved on from Texas Tech University to direct University of Arkansas's tech transfer operation.

Scout RFP has agreed to a $540m acquisition by its existing shareholder Workday, which will provide exits to Salesforce Ventures and GV.

Merck Global Health Innovation Fund and Bristol-Myers Squibb have provided the final tranche for PathAI’s $75m series B round, adding to an earlier commitment from LabCorp.

Goldman Sachs has led a $50m round for credit card provider Deserve, while existing shareholders including Sallie Mae also contributed.

Microsoft, Itochu and Samsung have invested in Volterra, which has emerged with $50m in funding after two years of developing its distributed cloud services technology in stealth.

Sumo Logic has purchased Dell-backed cybersecurity platform provider Jask Labs for an unspecified sum.